软骨肉瘤的研究趋势和焦点:一个图书统计和网络分析
Yuming Yao1,2, Ruhao Zhou3, Guang Yang1,2
1Department of Orthopedics, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Medicine
|November 13, 2024
概括
本研究分析了2000年至2023年的骨肉瘤研究趋势,确定了全球关键贡献者和机构. 未来的研究可能将重点放在耐火性软骨肉类瘤的向治疗方法上.
科学领域:
- 整形外科 整形外科 整形外科
- 在瘤学瘤学.
- 图书统计学 图书统计学
背景情况:
- 软骨肉瘤是一种常见的恶性骨瘤.
- 全球研究工作正在进行中,以了解和治疗这种疾病.
研究的目的:
- 为了确定领先的学者,机构和国家在冠状腺癌研究.
- 提供期刊提交建议,并探索研究趋势.
- 分析该领域的出版模式和协作网络.
主要方法:
- 来自Web of Science核心收藏 (2000-2023) 的2022年文章的文献分析.
- 使用R包的文献计数用于引用指标.
- 雇佣了VOSviewer用于网络分析和CiteSpace用于关键词爆发地图.
主要成果:
- 在冠状腺癌出版物中观察到平均年增长率为3.9%.
- 中国医学大学和莱顿大学是重要的贡献者.
- 中国的出版物数量迅速增加;美国在该领域处于领先地位.
- 唐欣被认为是最有影响力的作家.
结论:
- 冠状腺癌研究正在扩大,国际合作也在增加.
- 已经确定了关键机构和作者.
- 新兴的研究热点包括耐火性软骨肉类瘤的向治疗.
相关概念视频
Rous Sarcoma Virus (RSV) and Cancer
5.0K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.0K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Growth of Cartilage and Bone Tissue
3.1K
Chondrocytes form a temporary cartilaginous model by dividing and secreting a thick gel-like extracellular matrix. Once the chondrocytes undergo programmed cell death, osteoblasts enter the site of the cartilaginous model. The process of replacing the temporary cartilaginous model with bone in an ordered manner is called endochondral ossification. In endochondral ossification, not all of the cartilage is replaced by bone tissue. Some cartilage that performs a protective and supportive function...
3.1K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K


